Skip to main content
. 2020 Oct 22;11:2150132720965085. doi: 10.1177/2150132720965085

Table 3.

Summary of Associations of Clinical Parameters as Outcomes with the Main Independent Variable (Changes of MPR) using GEE (for HbA1c, SBP and DBP) and Logistic Regression (for LDL-C).

Clinical parameter Factors Odds ratio (95% CI) P-value
Decrease in HbA1ca Changes of MPR of OHGA 1.02 (1.00-1.04) .060
Group Control 1.00 .497
MDMPS 1.28 (0.63-2.60)
Decrease in SBPb Changes of MPR of HTN medication 0.99 (0.98-1.01) .305
Group Control 1.00 .411
MDMPS 0.80 (0.47-1.36)
Decrease in DBPb Changes of MPR of HTN medication 0.99 (0.97-1.00) .132
Group Control 1.00 .870
MDMPS 0.96 (0.55-1.65)
Decrease in LDL-Cc Changes of MPR of HLD medication 1.04 (1.01-1.07) .007**
Group Control 1.00 .359
MDMPS 0.65 (0.26-1.64)

Abbreviations: DBP: diastolic blood pressure; DM: type 2 diabetes mellitus; GEE: generalized estimating equation; HbA1c: glycated hemoglobin; HLD: hyperlipidemia; HTN: hypertension; LDL-C: low-density lipoprotein-cholesterol; MPR: medication possession ratio; OHGA: oral hypoglycemic agent; SBP: systolic blood pressure.

a

Covariates in GEE: Time (6 or 12-month index period), gender, race, use of insulin, age, baseline HbA1c, baseline MPR of OHGA, baseline number of chronic medications and baseline number of OHGA.

b

Covariates in GEE: Time (6 or 12-month index period), gender, race, age, baseline SBP or DBP, baseline MPR of HTN medications, baseline number of chronic medications and baseline number of HTN medications.

c

Covariates in Logistic regression: Gender, race, age, baseline LDL-C, baseline MPR of HLD medications, baseline number of chronic medications and baseline number of HLD medications.

**

P < .05.